DK0464845T3 - Pyrrolderivater - Google Patents
PyrrolderivaterInfo
- Publication number
- DK0464845T3 DK0464845T3 DK91111221.7T DK91111221T DK0464845T3 DK 0464845 T3 DK0464845 T3 DK 0464845T3 DK 91111221 T DK91111221 T DK 91111221T DK 0464845 T3 DK0464845 T3 DK 0464845T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrole
- hyperlipoproteinemia
- hypercholesterolemia
- hmg
- atherosclerosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17856490 | 1990-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0464845T3 true DK0464845T3 (da) | 1996-06-24 |
Family
ID=16050690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91111221.7T DK0464845T3 (da) | 1990-07-05 | 1991-07-05 | Pyrrolderivater |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5128366A (es) |
| EP (1) | EP0464845B1 (es) |
| JP (1) | JP3068665B2 (es) |
| KR (1) | KR0167781B1 (es) |
| AT (1) | ATE138909T1 (es) |
| CA (1) | CA2046146C (es) |
| DE (1) | DE69119979T2 (es) |
| DK (1) | DK0464845T3 (es) |
| ES (1) | ES2090177T3 (es) |
| GR (1) | GR3020689T3 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2687146B1 (fr) * | 1992-02-12 | 1994-04-01 | Adir Cie | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DE4243279A1 (de) * | 1992-12-21 | 1994-06-23 | Bayer Ag | Substituierte Triole |
| US6376476B1 (en) * | 1996-12-13 | 2002-04-23 | Zymogenetics Corporation | Isoprenoid pathway inhibitors for stimulating bone growth |
| US6083497A (en) | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| US6962999B2 (en) | 2001-07-25 | 2005-11-08 | Pharmacore, Inc. | Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles |
| CN1874767A (zh) * | 2003-10-29 | 2006-12-06 | 惠氏公司 | 包含aplindore和其衍生物的缓释药物组合物 |
| CA2582777A1 (en) | 2004-09-30 | 2006-04-06 | Takeda Pharmaceutical Company Limited | Proton pump inhibitors |
| ME00610B (me) | 2005-08-30 | 2011-12-20 | Takeda Pharmaceuticals Co | 1 –heterociklilsulfonil, 2 –aminometil, 5– (hetero–) aril supstituisan 1–h–pirol derivati kao inhibitori lučenja kiseline |
| US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| KR100856133B1 (ko) * | 2008-01-11 | 2008-09-03 | 조동옥 | 아토르바스타틴의 개선된 제조방법 |
| MY152008A (en) | 2008-08-27 | 2014-08-15 | Takeda Pharmaceutical | Pyrrole compounds |
| KR20200066690A (ko) | 2017-10-16 | 2020-06-10 | 칭화대학교 | 메발로네이트 경로 억제제 및 이의 약제학적 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987002662A2 (en) * | 1985-10-25 | 1987-05-07 | Sandoz Ag | Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals |
| NO881411L (no) * | 1987-04-14 | 1988-10-17 | Bayer Ag | Substituerte pyrroler. |
| IT1215578B (it) * | 1987-06-24 | 1990-02-14 | Roussel Maestretti Spa | Derivati di 1-arilsolfonil1,5-diidro 2h-pirrol 2-one, loro procedimento di preparazione e loro applicazione come sostanze medicinali. |
| DE3722806A1 (de) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | 7-(1h-pyrrol-3-yl)-substituierte 3,5-dihydroxy-hept-6-ensaeuren, 7-(1h-pyrrol-3-yl)-substituierte 3,5-dihydroxy-heptansaeuren, ihre entsprechenden (delta)-lactone und salze, verfahren zu ihrer herstellung ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
| US5003080A (en) * | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
-
1991
- 1991-05-30 US US07/707,805 patent/US5128366A/en not_active Expired - Fee Related
- 1991-05-31 JP JP3157518A patent/JP3068665B2/ja not_active Expired - Fee Related
- 1991-07-03 CA CA002046146A patent/CA2046146C/en not_active Expired - Fee Related
- 1991-07-04 KR KR1019910011332A patent/KR0167781B1/ko not_active IP Right Cessation
- 1991-07-05 DK DK91111221.7T patent/DK0464845T3/da active
- 1991-07-05 EP EP91111221A patent/EP0464845B1/en not_active Expired - Lifetime
- 1991-07-05 DE DE69119979T patent/DE69119979T2/de not_active Expired - Fee Related
- 1991-07-05 AT AT91111221T patent/ATE138909T1/de not_active IP Right Cessation
- 1991-07-05 ES ES91111221T patent/ES2090177T3/es not_active Expired - Lifetime
-
1996
- 1996-07-31 GR GR960402047T patent/GR3020689T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69119979D1 (de) | 1996-07-11 |
| ATE138909T1 (de) | 1996-06-15 |
| CA2046146A1 (en) | 1992-01-06 |
| KR0167781B1 (ko) | 1999-01-15 |
| EP0464845A1 (en) | 1992-01-08 |
| GR3020689T3 (en) | 1996-10-31 |
| CA2046146C (en) | 1997-02-25 |
| JP3068665B2 (ja) | 2000-07-24 |
| DE69119979T2 (de) | 1996-10-24 |
| KR920002536A (ko) | 1992-02-28 |
| US5128366A (en) | 1992-07-07 |
| EP0464845B1 (en) | 1996-06-05 |
| ES2090177T3 (es) | 1996-10-16 |
| JPH04352767A (ja) | 1992-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU0004863D0 (es) | ||
| DE69430279D1 (de) | Pyrimidinverbindungen und ihre Verwendung als Pharmazeutika | |
| DK0464845T3 (da) | Pyrrolderivater | |
| MX9303594A (es) | Oximas piridino, pirrolidino y azepino substituidas utiles como agentes antiateroscleroticos y antihipercolesterolemicos. | |
| PT934325E (pt) | Trisanidridos biciclicos de tetrafosfonato | |
| DE59708471D1 (de) | Stabilisierung von Metallkonjugaten | |
| EP0529854A3 (en) | Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors | |
| DE69313846D1 (de) | Vielseitiger, doppelt wirkender müllbehälterdeckel | |
| GR880100332A (el) | ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ ΡΕΔΟΥΚΤΑΣΗΣ HMG-CοA ΠΟΥ ΠΕΡΙΕΧΕΙ ΦΩΣΦΟΡΟ,ΝΕΑ ΕΝΔΙΑΜΕΣΑ ΚΑΙ ΜΕΘΟΔΟΣ | |
| DE59507596D1 (de) | Verbindung von Backrohr und Backrohr-Aufnahmerahmen | |
| MY118381A (en) | Statin-carboxyalkylether combinations | |
| DE69510729T2 (de) | Suspensionskonzentrat von insektiziden und akariziden Arylpyrrolen | |
| NO996206D0 (no) | Farnesyltransferase inhibitorer i kombinasjon med HMG COA reduktase inhibitorer for behandling av cancer | |
| NO905291D0 (no) | Fremgangsmaate for behandling av sinkholdige biprodukter og avfallsmaterialer. | |
| DE69103919D1 (de) | Diaminoverbindungen und Vorstufe dafür. | |
| DE69409961D1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
| PT751775E (pt) | Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos | |
| IT1255470B (it) | Composti attivi come inibitori dell'enzima hmg-coa reduttasi | |
| NO923862L (no) | Inhibitorer for hmg-coa-reduktase | |
| AU5550990A (en) | Novel hmg coa reductase inhibitors | |
| TR27040A (tr) | Halojenlenmis alkeniltio sübstitüeli pirimidin bilesikleri. | |
| FI933236A0 (fi) | Foerfarande foer frekvensval i soekanordning | |
| ES1030211Y (es) | Disposicion sustentadora de recipientes. |